{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:57:45Z","timestamp":1791269865111,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.biotechadv.2010.11.008","type":"journal-article","created":{"date-parts":[[2010,12,12]],"date-time":"2010-12-12T09:04:58Z","timestamp":1292144698000},"page":"239-247","source":"Crossref","is-referenced-by-count":145,"title":["Review of dengue virus and the development of a vaccine"],"prefix":"10.1016","volume":"29","author":[{"given":"Sarah","family":"Murrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suh-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/S0950268804003541","article-title":"Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002","volume":"133","author":"Anantapreecha","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.antiviral.2008.06.005","article-title":"Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates","volume":"80","author":"Bernardo","year":"2008","journal-title":"Antivir Res"},{"issue":"12","key":"10.1016\/j.biotechadv.2010.11.008_bb0015","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/CVI.00191-09","article-title":"Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes","volume":"16","author":"Bernardo","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.biotechadv.2010.11.008_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(00)00233-1","article-title":"Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains","volume":"73","author":"Bielefeldt-Ohmann","year":"2001","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.biotechadv.2010.11.008_bb0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.vaccine.2007.11.082","article-title":"Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3\u2032 untranslated region (3\u2032-UTR) or by exchange of the DENV-3 3\u2032-UTR with that of DENV-4","volume":"26","author":"Blaney","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-642-02215-9_11","article-title":"Targeted mutagenesis as a rational approach to dengue virus vaccine development","volume":"338","author":"Blaney","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0035","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1371\/journal.pntd.0000096","article-title":"Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus","volume":"1","author":"Brandler","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.biotechadv.2010.11.008_bb0040","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0035-9203(87)90041-1","article-title":"Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever\/dengue shock syndrome (DHF\/DSS)","volume":"81","author":"Bravo","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"21","key":"10.1016\/j.biotechadv.2010.11.008_bb0045","doi-asserted-by":"crossref","first-page":"11634","DOI":"10.1128\/JVI.00996-07","article-title":"A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"issue":"7195","key":"10.1016\/j.biotechadv.2010.11.008_bb0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nature07013","article-title":"CLEC5A is critical for dengue-virus-induced lethal disease","volume":"453","author":"Chen","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biotechadv.2010.11.008_bb0055","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/infdis\/170.5.1304","article-title":"Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection","volume":"170","author":"Chungue","year":"1994","journal-title":"J Infect Dis"},{"issue":"5853","key":"10.1016\/j.biotechadv.2010.11.008_bb0060","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.318.5853.1048","article-title":"AIDS research. Did Merck's failed HIV vaccine cause harm?","volume":"318","author":"Cohen","year":"2007","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.biotechadv.2010.11.008_bb0065","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1099\/0022-1317-75-7-1569","article-title":"Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice","volume":"75","author":"Delenda","year":"1994","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.biotechadv.2010.11.008_bb0070","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0042-6822(91)90055-G","article-title":"Processing, secretion, and immunoreactivity of carboxyl terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses","volume":"180","author":"Deubel","year":"1991","journal-title":"Virology"},{"issue":"Suppl 1","key":"10.1016\/j.biotechadv.2010.11.008_bb0075","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1086\/518148","article-title":"Dengue vaccines approach the finish line","volume":"45","author":"Edelman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.biotechadv.2010.11.008_bb0080","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1371\/journal.pntd.0000411","article-title":"Use of mapping and spatial and space-time modeling approaches in operational control of Aedes aegypti and Dengue","volume":"3","author":"Eisen","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4269\/ajtmh.2008.79.353","article-title":"An envelope domain III-based chimeric antigen produced in Pchia pastoris elicits neutralizing antibodies against all four dengue virus serotypes","volume":"79","author":"Etemad","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0090","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1371\/journal.pntd.0000617","article-title":"Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006","volume":"4","author":"Fried","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.biotechadv.2010.11.008_bb0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.qco.0000244047.31135.fa","article-title":"Immunopathological mechanisms in dengue and dengue hemorrhagic fever","volume":"19","author":"Green","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-3527(08)60342-5","article-title":"Impact of dengue\/dengue hemorrhagic fever on the developing world","volume":"53","author":"Gubler","year":"1999","journal-title":"Adv Virus Res"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"issue":"2\u20133","key":"10.1016\/j.biotechadv.2010.11.008_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cimid.2007.07.011","article-title":"Towards a dengue vaccine: progress to date and remaining challenges","volume":"31","author":"Guy","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.biotechadv.2010.11.008_bb0115","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1386-6532(09)70290-2","article-title":"Immunogenicity of Sanofi Pasteur tetravalent dengue vaccine","volume":"46","author":"Guy","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0120","first-page":"96","article-title":"Hemorrhagic fever in Thailand newer knowledge regarding etiology","volume":"20","author":"Halstead","year":"1967","journal-title":"Jpn J Med Sci Biol"},{"issue":"6 Suppl","key":"10.1016\/j.biotechadv.2010.11.008_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690005","article-title":"Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii","volume":"69","author":"Halstead","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"4839","key":"10.1016\/j.biotechadv.2010.11.008_bb0130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"issue":"Suppl 4","key":"10.1016\/j.biotechadv.2010.11.008_bb0135","doi-asserted-by":"crossref","first-page":"S830","DOI":"10.1093\/clinids\/11.Supplement_4.S830","article-title":"Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade","volume":"11","author":"Halstead","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0140","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.131.3407.1102","article-title":"Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand","volume":"131","author":"Hammon","year":"1960","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biotechadv.2010.11.008_bb0145","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CMR.3.4.376","article-title":"The dengue viruses","volume":"3","author":"Henchal","year":"1990","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2003.09.024","article-title":"A dengue-2 envelope fragment inserted within the structure of the P64K meningococcal protein carrier enables a functional immune response against the virus in mice","volume":"115","author":"Hermida","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0155","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/j.vaccine.2006.01.036","article-title":"A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective I nonhuman primates","volume":"24","author":"Hermida","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biotechadv.2010.11.008_bb0160","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1590\/S1020-49892007000300011","article-title":"Vaccines against dengue: a review of current candidate vaccines at advanced development stages","volume":"21","author":"Hombach","year":"2007","journal-title":"Rev Panam Salud P\u00fablica"},{"issue":"1","key":"10.1016\/j.biotechadv.2010.11.008_bb0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","article-title":"An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells","volume":"78","author":"Hung","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.micro.62.081307.163005","article-title":"Global spread and persistence of dengue","volume":"62","author":"Kyle","year":"2008","journal-title":"Annu Rev Microbiol"},{"issue":"10","key":"10.1016\/j.biotechadv.2010.11.008_bb0180","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1371\/journal.pntd.0000311","article-title":"Dermal-type macrophages expressing CD209\/DC-SIGN show inherent resistance to dengue virus growth","volume":"2","author":"Kwan","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.biotechadv.2010.11.008_bb0185","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1073\/pnas.88.12.5139","article-title":"Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus","volume":"88","author":"Lai","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.biotechadv.2010.11.008_bb0190","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II","volume":"82","author":"Lai","year":"2008","journal-title":"J Virol"},{"issue":"Suppl 2","key":"10.1016\/j.biotechadv.2010.11.008_bb0195","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S1386-6532(09)70291-4","article-title":"Recent progress on Sanofi Pasteur's dengue vaccine candidate","volume":"46","author":"Lang","year":"2009","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.micinf.2008.12.004","article-title":"A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity","volume":"11","author":"Leng","year":"2009","journal-title":"Microbes Infect"},{"issue":"10","key":"10.1016\/j.biotechadv.2010.11.008_bb0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4161\/hv.6.10.13018","article-title":"Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas","volume":"6","author":"Letson","year":"2010","journal-title":"Hum Vaccin"},{"issue":"5","key":"10.1016\/j.biotechadv.2010.11.008_bb0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/bit.10918","article-title":"Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variation in virus titer, plaque morphology, and replication rate","volume":"85","author":"Liu","year":"2004","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0215","doi-asserted-by":"crossref","first-page":"e1810","DOI":"10.1371\/journal.pone.0001810","article-title":"High genetic stability of dengue virus propagated in MRC-5 cells as compared to the virus propagated in vero cells","volume":"3","author":"Liu","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0225","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0042-6822(92)90450-4","article-title":"Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue envelope glycoprotein","volume":"187","author":"Megret","year":"1992","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0230","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1128\/JVI.65.3.1400-1407.1991","article-title":"Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice","volume":"65","author":"Men","year":"1991","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.biotechadv.2010.11.008_bb0235","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.70.6.3930-3937.1996","article-title":"Dengue type 4 virus mutants containing deletions in the 3\u2032 noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys","volume":"70","author":"Men","year":"1996","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0240","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1371\/journal.ppat.0040017","article-title":"The mannose receptor mediates dengue virus infection of macrophages","volume":"4","author":"Miller","year":"2008","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.biotechadv.2010.11.008_bb0245","first-page":"31","article-title":"Recent progress in dengue vaccine research and development","volume":"12","author":"Miller","year":"2010","journal-title":"Curr Opinion Mol Ther"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0250","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/clinids\/19.3.500","article-title":"Antibody-dependent enhancement of infection and the pathogenesis of viral disease","volume":"19","author":"Morens","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0255","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.biotechadv.2010.11.008_bb0260","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2009-09-242990","article-title":"Dengue virus-induced hemorrhage in a nonhuman primate model","volume":"115","author":"Onlamoon","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0265","series-title":"Clinical and preclinical evaluation of DENVax, a tetravalent DEN-2 PDK-53-based chimeric dengue vaccine. Singapore","article-title":"The fourth Asian dengue research network meeting","author":"Osorio","year":"2009"},{"issue":"7","key":"10.1016\/j.biotechadv.2010.11.008_bb0270","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/77470","article-title":"Dengue virus and dendritic cells","volume":"6","author":"Palucka","year":"2000","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.biotechadv.2010.11.008_bb0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2005.11.042","article-title":"Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN","volume":"124","author":"Pokidysheva","year":"2006","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biotechadv.2010.11.008_bb0280","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4269\/ajtmh.2003.68.469","article-title":"Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes","volume":"68","author":"Putnak","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"14","key":"10.1016\/j.biotechadv.2010.11.008_bb0285","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/JVI.02724-07","article-title":"A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus","volume":"82","author":"Raviprakash","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0290","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2\u00c5 resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0295","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0042-6822(90)90102-W","article-title":"Molecular evolution and distribution of dengue viruses type 1 and 2 in nature","volume":"174","author":"Rico-Hesse","year":"1990","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.biotechadv.2010.11.008_bb0300","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1172\/JCI21512","article-title":"Dengue: defining protective versus pathologic immunity","volume":"113","author":"Rothman","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-642-02215-9_7","article-title":"Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis","volume":"338","author":"Rothman","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.biotechadv.2010.11.008_bb0310","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.biotechadv.2010.11.008_bb0315","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0320","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virol.2003.09.048","article-title":"Early activation of natural killer and B cells in response to primary dengue virus infection in A\/J mice","volume":"319","author":"Shresta","year":"2004","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.biotechadv.2010.11.008_bb0325","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.biotechadv.2010.11.008_bb0330","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/JVI.78.6.2701-2710.2004","article-title":"Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical","volume":"78","author":"Shresta","year":"2004","journal-title":"J Virol"},{"issue":"Suppl 3","key":"10.1016\/j.biotechadv.2010.11.008_bb0335","first-page":"S363","article-title":"Dengue vaccine","volume":"88","author":"Simasathien","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0340","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.1998.58.655","article-title":"Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice","volume":"58","author":"Simmons","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0345","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0264-410X(94)00059-V","article-title":"Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection","volume":"13","author":"Srivastava","year":"1995","journal-title":"Vaccine"},{"issue":"6 Suppl","key":"10.1016\/j.biotechadv.2010.11.008_bb0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690024","article-title":"Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates","volume":"69","author":"Sun","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.biotechadv.2010.11.008_bb0355","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4269\/ajtmh.2008.78.990","article-title":"Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic","volume":"78","author":"Thomas","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.biotechadv.2010.11.008_bb0360","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3201\/eid1004.030216","article-title":"Myanmar dengue outbreak associated with displacement of serotypes 2, 3, and 4 by dengue 1","volume":"10","author":"Thu","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2010.10.043","article-title":"WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines, Geneva, Switzerland, 11\u201312 May 2009","author":"Trent","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0370","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.08.029","article-title":"A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice","volume":"394","author":"Valdes","year":"2009","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.biotechadv.2010.11.008_bb0375","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.biotechadv.2010.11.008_bb0380","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0385","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/JVI.77.2.1653-1657.2003","article-title":"A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3\u2032 untranslated region is highly attenuated and immunogenic in monkeys","volume":"77","author":"Whitehead","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0390","author":"World Health Organization, W.P.R."},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0395","author":"World Health Organization"},{"key":"10.1016\/j.biotechadv.2010.11.008_bb0400","author":"World Health Organization"},{"issue":"5","key":"10.1016\/j.biotechadv.2010.11.008_bb0405","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4269\/ajtmh.2009.09-0131","article-title":"Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers","volume":"81","author":"Wright","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.biotechadv.2010.11.008_bb0410","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/77553","article-title":"Human skin Langerhans cells are targets of dengue virus infection","volume":"6","author":"Wu","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.biotechadv.2010.11.008_bb0415","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(98)00036-7","article-title":"Yellow fever 17D vaccine virus isolated from healthy vaccines accumulates very few mutations","volume":"55","author":"Xie","year":"1998","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.biotechadv.2010.11.008_bb0420","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.antiviral.2008.06.010","article-title":"Mouse models of dengue virus infection and disease","volume":"80","author":"Yauch","year":"2008","journal-title":"Antiviral Res"},{"issue":"16","key":"10.1016\/j.biotechadv.2010.11.008_bb0425","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1016\/j.vaccine.2007.01.064","article-title":"Attenuated measles virus as a vaccine vector","volume":"25","author":"Zuniga","year":"2007","journal-title":"Vaccine"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975010001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975010001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T16:11:47Z","timestamp":1592151107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975010001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0734975010001655"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2010.11.008","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}